Analyses on K-ras mutations and fascin expression in patients with cardia cancer

Li Wei1, Haiyan Chang2, Song Huo3

  • 1Department of Pathology, Jining First People's Hospital, Jining, Shandong 272111, P.R. China.

Oncology Letters
|January 25, 2019
PubMed

Insights

Cardia cancer patients with K-ras gene mutations, particularly at codon 12, show significantly higher fascin protein expression. Alcohol abuse is identified as a risk factor for these K-ras mutations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cardia cancer is a significant health concern globally.
  • K-ras gene mutations are implicated in various cancers.
  • Fascin is a protein involved in cell motility and cancer progression.

Purpose of the Study:

  • To investigate K-ras gene mutations in cardia cancer patients.
  • To analyze the effect of K-ras mutations on fascin expression.
  • To identify potential risk factors for K-ras mutations in cardia cancer.

Main Methods:

  • Genomic DNA extraction from cardia cancer tissues.
  • Pyrosequencing and quantitative polymerase chain reaction (qPCR) for K-ras mutation detection.
  • Immunohistochemistry and qPCR for fascin expression analysis.

Main Results:

  • K-ras mutations were found in 23.3% of cardia cancer patients, predominantly in exon 12.
  • Alcohol abuse was identified as a significant risk factor for K-ras mutations.
  • Fascin expression was significantly higher (2.3-fold) in patients with K-ras mutations compared to those without.

Conclusions:

  • Codon 12 mutations in the K-ras gene are common in cardia cancer.
  • Fascin is highly expressed in cardia cancer patients with K-ras mutations.
  • Fascin expression is positively correlated with K-ras gene mutations in cardia cancer.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.3K
Mutations01:39

Mutations

Overview
94.5K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.4K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K